A detailed history of Hobbs Group Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hobbs Group Advisors, LLC holds 12,494 shares of NVO stock, worth $1.09 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
12,494
Previous 12,912 3.24%
Holding current value
$1.09 Million
Previous $1.84 Billion 19.29%
% of portfolio
0.53%
Previous 0.7%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

SELL
$119.07 - $145.42 $49,771 - $60,785
-418 Reduced 3.24%
12,494 $1.49 Billion
Q2 2024

Jul 22, 2024

BUY
$122.71 - $146.91 $1.19 Million - $1.43 Million
9,734 Added 306.29%
12,912 $1.84 Billion
Q4 2023

Feb 16, 2024

BUY
$87.78 - $105.45 $278,964 - $335,120
3,178 New
3,178 $329 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hobbs Group Advisors, LLC Portfolio

Follow Hobbs Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobbs Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobbs Group Advisors, LLC with notifications on news.